185 related articles for article (PubMed ID: 25027801)
1. Development of radamide analogs as Grp94 inhibitors.
Muth A; Crowley V; Khandelwal A; Mishra S; Zhao J; Hall J; Blagg BS
Bioorg Med Chem; 2014 Aug; 22(15):4083-98. PubMed ID: 25027801
[TBL] [Abstract][Full Text] [Related]
2. Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.
Crowley VM; Khandelwal A; Mishra S; Stothert AR; Huard DJ; Zhao J; Muth A; Duerfeldt AS; Kizziah JL; Lieberman RL; Dickey CA; Blagg BS
J Med Chem; 2016 Apr; 59(7):3471-88. PubMed ID: 27003516
[TBL] [Abstract][Full Text] [Related]
3. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design.
Immormino RM; Metzger LE; Reardon PN; Dollins DE; Blagg BS; Gewirth DT
J Mol Biol; 2009 May; 388(5):1033-42. PubMed ID: 19361515
[TBL] [Abstract][Full Text] [Related]
4. Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
Que NLS; Crowley VM; Duerfeldt AS; Zhao J; Kent CN; Blagg BSJ; Gewirth DT
J Med Chem; 2018 Apr; 61(7):2793-2805. PubMed ID: 29528635
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis.
Jiang F; Guo AP; Xu JC; You QD; Xu XL
J Med Chem; 2018 Nov; 61(21):9513-9533. PubMed ID: 30351001
[TBL] [Abstract][Full Text] [Related]
6. Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.
Crowley VM; Huard DJE; Lieberman RL; Blagg BSJ
Chemistry; 2017 Nov; 23(62):15775-15782. PubMed ID: 28857290
[TBL] [Abstract][Full Text] [Related]
7. Development of a Grp94 inhibitor.
Duerfeldt AS; Peterson LB; Maynard JC; Ng CL; Eletto D; Ostrovsky O; Shinogle HE; Moore DS; Argon Y; Nicchitta CV; Blagg BS
J Am Chem Soc; 2012 Jun; 134(23):9796-804. PubMed ID: 22642269
[TBL] [Abstract][Full Text] [Related]
8. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.
Mishra SJ; Ghosh S; Stothert AR; Dickey CA; Blagg BS
ACS Chem Biol; 2017 Jan; 12(1):244-253. PubMed ID: 27959508
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
Clevenger RC; Blagg BS
Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
Hadden MK; Blagg BS
J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence.
Dejeans N; Glorieux C; Guenin S; Beck R; Sid B; Rousseau R; Bisig B; Delvenne P; Buc Calderon P; Verrax J
Free Radic Biol Med; 2012 Mar; 52(6):993-1002. PubMed ID: 22245095
[TBL] [Abstract][Full Text] [Related]
12. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. II. Ligand-mediated activation of GRP94 molecular chaperone and peptide binding activity.
Wassenberg JJ; Reed RC; Nicchitta CV
J Biol Chem; 2000 Jul; 275(30):22806-14. PubMed ID: 10816560
[TBL] [Abstract][Full Text] [Related]
13. The ATPase cycle of the endoplasmic chaperone Grp94.
Frey S; Leskovar A; Reinstein J; Buchner J
J Biol Chem; 2007 Dec; 282(49):35612-20. PubMed ID: 17925398
[TBL] [Abstract][Full Text] [Related]
14. RNAi silenced Dd-grp94 (Dictyostelium discoideum glucose-regulated protein 94 kDa) cell lines in Dictyostelium exhibit marked reduction in growth rate and delay in development.
Baviskar SN; Shields MS
Gene Expr; 2010; 15(2):75-87. PubMed ID: 21526718
[TBL] [Abstract][Full Text] [Related]
15. Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum Hsp90 chaperone GRP94.
Wearsch PA; Voglino L; Nicchitta CV
Biochemistry; 1998 Apr; 37(16):5709-19. PubMed ID: 9548957
[TBL] [Abstract][Full Text] [Related]
16. The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis.
Reddy RK; Lu J; Lee AS
J Biol Chem; 1999 Oct; 274(40):28476-83. PubMed ID: 10497210
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of heat shock protein 70 and glucose-regulated protein 94 in human gastric carcinoma cell line BGC-823.
Wang XP; Liao J; Liu GZ; Wang XC; Shang HW
World J Gastroenterol; 2005 Jun; 11(23):3601-4. PubMed ID: 15962384
[TBL] [Abstract][Full Text] [Related]
18. Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding.
Rosser MF; Nicchitta CV
J Biol Chem; 2000 Jul; 275(30):22798-805. PubMed ID: 10816561
[TBL] [Abstract][Full Text] [Related]
19. Adenosine nucleotides and the regulation of GRP94-client protein interactions.
Rosser MF; Trotta BM; Marshall MR; Berwin B; Nicchitta CV
Biochemistry; 2004 Jul; 43(27):8835-45. PubMed ID: 15236592
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of heat shock protein 90 isoforms in small cell lung cancer.
Lee JH; Kang KW; Kim JE; Hwang SW; Park JH; Kim SH; Ji JH; Kim TG; Nam HY; Roh MS; Lee EH; Park MI; Kim MS; Lee HW
Int J Clin Exp Pathol; 2015; 8(8):9487-93. PubMed ID: 26464709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
